Reditux (100 mg/10 ml & 500 mg/50 ml)

Dr. Reddys Laboratories Ltd

REDITUX contains Drug / Molecule called “Rituximab”. Reditux is produced through recombinant DNA technology. Reditux is a monoclonal antibody against the protein found on the surface of immune system B cells. It induces cell death through antibody dependent cellular toxicity, complement dependent cytotoxicity, or apoptosis pathway.

Indication

Reditux is used for certain types of cancer such as Lymphomas, Leukemia, Transplant Rejection and some autoimmune disorders. Reditux may be used alone or in combination with other drugs for the treatment of Non-Hodgkin’s Lymphoma and rheumatoid arthritis.

Note

Precaution

  • Reditux is a prescription drug and should be used under proper medical guidance and advice.
  • It is not recommended if severe active infection is present.
  • May cause fatal renal toxicity in patients with hematologic malignancies.